12/1
09:00 am
cvkd
Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors
Low
Report
Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors
11/19
08:00 am
cvkd
Cadrenal Therapeutics CEO, Quang X. Pham, Receives BioFlorida’s Executive of the Year Award
Medium
Report
Cadrenal Therapeutics CEO, Quang X. Pham, Receives BioFlorida’s Executive of the Year Award
11/17
03:25 pm
cvkd
Why the underdog mindset could be your business superpower [Yahoo! Finance]
Low
Report
Why the underdog mindset could be your business superpower [Yahoo! Finance]
11/10
03:55 pm
cvkd
Cadrenal Therapeutics GAAP EPS of -$1.31 beats by $0.18 [Seeking Alpha]
Low
Report
Cadrenal Therapeutics GAAP EPS of -$1.31 beats by $0.18 [Seeking Alpha]
11/10
09:00 am
cvkd
Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Low
Report
Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
11/8
12:52 pm
cvkd
Cadrenal Therapeutics, Inc. [Yahoo! Finance]
Low
Report
Cadrenal Therapeutics, Inc. [Yahoo! Finance]
9/29
04:56 pm
cvkd
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 [Yahoo! Finance]
Medium
Report
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 [Yahoo! Finance]
9/29
04:30 pm
cvkd
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
Low
Report
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
9/15
08:39 am
cvkd
Cadrenal Therapeutics Enhances Anticoagulation Pipeline Through Acquisition of eXIthera's Portfolio of Factor XIa Inhibitors [Yahoo! Finance]
Low
Report
Cadrenal Therapeutics Enhances Anticoagulation Pipeline Through Acquisition of eXIthera's Portfolio of Factor XIa Inhibitors [Yahoo! Finance]
9/15
08:00 am
cvkd
Cadrenal Therapeutics Enhances Anticoagulation Pipeline Through Acquisition of eXIthera’s Portfolio of Factor XIa Inhibitors
Low
Report
Cadrenal Therapeutics Enhances Anticoagulation Pipeline Through Acquisition of eXIthera’s Portfolio of Factor XIa Inhibitors